AGN News and Press, Allergan plc From 03/23/20

Co-produced by Stanford Chemist Since covering Tekla Healthcare Investors ( HQH ) on October 20th, 2019, the fund had been charging higher at an incredible pace. Shares have since joined the rest of the market and are moving downward in a dramatic fashion. This is a fund that invests in ...

AbbVie (NYSE: ABBV ) has extended the expiration date for its exchange offer for certain outstanding notes issued by Allergan (NYSE: AGN ) to April 10 from March 27. More news on: AbbVie Inc., Allergan plc, Healthcare stocks news, Merger & acquisition news, Read more ...

Don’t Double Count I am sympathetic to most bearish sentiments (see here and here ), but am trying to be careful to not double count our problems. For example, I am quite concerned about Covid-19, but am wary of a lot of the statistics floating around the media. For example, some...

VANCOUVER, British Columbia, March 19, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company is pleased to announce that Novotech, ...

In June, AbbVie (NYSE: ABBV) made a bid to purchase Allergan (NYSE: AGN) in a cash and stock transaction valued at $63 billion. AbbVie likely decided to pursue the massive acquisition in part to decrease its reliance on its best-selling drug Humira, sales of which have been declining i...

Allergan (NYSE: AGN ) declares $0.74/share quarterly dividend , in line with previous. More news on: Allergan plc, Dividend News, Read more ...

DUBLIN , March 18, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the second quarter of 2020. The dividend will be paid on the closing date of AbbVie's pending acquisition of All...

NORTH CHICAGO, Ill. and DUBLIN , March 17, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, and Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that they have entered into a consent decree agreement with...

Teva Pharmaceutical Industries ( TEVA -11.1% ) announces the availability of Herzuma (trastuzumab-pkrb), a biosimilar to Roche's ( OTCQX:RHHBY   -4% ) Herceptin, in the U.S. More news on: Teva Pharmaceutical Industries Limited, Roche Holding Ltd ADR, Amgen Inc., Healthcare stocks ...

VANCOUVER, British Columbia, March 13, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company is pleased to announce that is has fil...